99 related articles for article (PubMed ID: 7524407)
1. Significance of the regulation of plasma kallikrein by alpha 2M.
Colman RW
Ann N Y Acad Sci; 1994 Sep; 737():347-67. PubMed ID: 7524407
[No Abstract] [Full Text] [Related]
2. High molecular weight kininogen or its light chain protects human plasma kallikrein from inactivation by plasma protease inhibitors.
Schapira M; Scott CF; James A; Silver LD; Kueppers F; James HL; Colman RW
Biochemistry; 1982 Feb; 21(3):567-72. PubMed ID: 6175341
[No Abstract] [Full Text] [Related]
3. High molecular weight kininogen potentiates the heparin-accelerated inhibition of plasma kallikrein by antithrombin: role for antithrombin in the regulation of kallikrein.
Olson ST; Sheffer R; Francis AM
Biochemistry; 1993 Nov; 32(45):12136-47. PubMed ID: 7692967
[TBL] [Abstract][Full Text] [Related]
4. Role of high molecular weight kininogen in modulating the inactivation of human plasma kallikrein by plasma protease inhibitors.
Schapira M; James A; Scott CF; Kueppers F; James HL; Cohen AB; Colman RW
Adv Exp Med Biol; 1983; 156():131-41. PubMed ID: 6190364
[No Abstract] [Full Text] [Related]
5. Inactivation of kallikrein in human plasma.
van der Graaf F; Koedam JA; Bouma BN
J Clin Invest; 1983 Jan; 71(1):149-58. PubMed ID: 6184384
[TBL] [Abstract][Full Text] [Related]
6. Interaction of plasma kallikrein with plasma proteinase inhibitors.
Salvesen G; Virca GD; Travis J
Adv Exp Med Biol; 1983; 156():121-30. PubMed ID: 6190363
[No Abstract] [Full Text] [Related]
7. alpha2-macroglobulin and C1-inactivator are plasma inhibitors of human glandular kallikrein.
Heeb MJ; España F
Blood Cells Mol Dis; 1998 Dec; 24(4):412-9. PubMed ID: 9851894
[TBL] [Abstract][Full Text] [Related]
8. Binding of a monoclonal anti-human plasma prekallikrein antibody to the complexes of kallikrein with C1-inhibitor and alpha 2-macroglobulin analyzed by immunoblot and "sandwich" assays.
Veloso D; Tseng SY; Craig AR; Colman RW
Adv Exp Med Biol; 1989; 247A():499-505. PubMed ID: 2481391
[No Abstract] [Full Text] [Related]
9. Plasma kallikrein activation and inhibition during typhoid fever.
Colman RW; Edelman R; Scott CF; Gilman RH
J Clin Invest; 1978 Feb; 61(2):287-96. PubMed ID: 74379
[TBL] [Abstract][Full Text] [Related]
10. Prekallikrein activation and kallikrein inactivation in human plasma.
van der Graaf F; Keus JF; Koedam JA; Rietveld A; Bouma BN
Adv Exp Med Biol; 1983; 156():143-8. PubMed ID: 6190365
[No Abstract] [Full Text] [Related]
11. The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia. In vivo use of a monoclonal anti-factor XII antibody to block contact activation in baboons.
Pixley RA; De La Cadena R; Page JD; Kaufman N; Wyshock EG; Chang A; Taylor FB; Colman RW
J Clin Invest; 1993 Jan; 91(1):61-8. PubMed ID: 7678610
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the formation and inhibition of human plasma kallikrein.
Colman RW; Schapira M; Scott CF
Ann N Y Acad Sci; 1981; 370():261-70. PubMed ID: 6943960
[No Abstract] [Full Text] [Related]
13. Computerized immunoblot analyses (CIBA) of the distribution of prekallikrein and its activation products in vivo and in vitro.
Veloso D; Campbell G
Agents Actions Suppl; 1992; 38 ( Pt 1)():166-73. PubMed ID: 1281607
[TBL] [Abstract][Full Text] [Related]
14. Mononuclear cell chemotactic activity of kallikrein and plasminogen activator and its inhibition by C1 inhibitor and alpha 2-macroglobulin.
Gallin JI; Kaplan AP
J Immunol; 1974 Dec; 113(6):1928-34. PubMed ID: 4214866
[No Abstract] [Full Text] [Related]
15. C1 inhibitor: the main inhibitor of human plasma kallikrein.
Trumpi-Kalshoven MM; Kluft C
Adv Biosci; 1978 Jul; 17():93-101. PubMed ID: 90628
[No Abstract] [Full Text] [Related]
16. Immunoblotting of plasma in a pregnant patient with hereditary angioedema.
Chhibber G; Cohen A; Lane S; Farber A; Meloni FJ; Schmaier AH
J Lab Clin Med; 1990 Jan; 115(1):112-21. PubMed ID: 1688910
[TBL] [Abstract][Full Text] [Related]
17. Protection of human plasma kallikrein from inactivation by C1 inhibitor and other protease inhibitors. The role of high molecular weight kininogen.
Schapira M; Scott CF; Colman RW
Biochemistry; 1981 May; 20(10):2738-43. PubMed ID: 6910423
[TBL] [Abstract][Full Text] [Related]
18. Characterization of human salivary kallikrein: reactivities to human plasma kininogens and proteinase inhibitors.
Sakamoto W; Yoshikawa K; Uehara S; Nishikaze O
J Biochem; 1983 Mar; 93(3):833-8. PubMed ID: 6553577
[TBL] [Abstract][Full Text] [Related]
19. Cold promoted activation and factor XII, prekallikrein and C1-inhibitor.
Czendlik C; Lämmle B; Duckert F
Thromb Haemost; 1985 Apr; 53(2):242-4. PubMed ID: 2410997
[TBL] [Abstract][Full Text] [Related]
20. Contribution of plasma protease inhibitors to the inactivation of kallikrein in plasma.
Schapira M; Scott CF; Colman RW
J Clin Invest; 1982 Feb; 69(2):462-8. PubMed ID: 6173399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
